文献速递肥胖与代谢综合征

体重指数与COVID-19诊断、住院及死亡风险:252万加泰罗尼亚人群队列研究

Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

结果显示BMI与诊断和住院风险呈正相关,与死亡风险呈J型关系,且年轻人群中风险增加更明显。

要点

  • BMI升高与COVID-19诊断及住院风险增加呈单调正相关。
  • BMI与COVID-19后续死亡风险呈J型关系,低体重和极高BMI均增加风险。
  • 年轻人群中BMI相关的COVID-19不良结局风险增加更为显著。

核心结论

  • BMI与COVID-19诊断和住院风险呈单调正相关,与后续死亡风险呈J型关系。

主要发现

  • 相比BMI 22 kg/m2,BMI 31 kg/m2的诊断HR为1.22(95%CI 1.19-1.24)。
  • BMI 31 kg/m2的无既往门诊诊断住院HR为1.88(95%CI 1.75-2.03),有既往门诊诊断住院HR为2.01(95%CI 1.86-2.18)。
  • BMI与后续死亡呈J型关系,BMI≤19 kg/m2风险轻度升高,BMI≥40 kg/m2风险增加更明显。
  • 年轻患者中COVID-19结局风险增加尤为显著。

临床怎么用

  • 在内分泌科评估肥胖患者时,应关注其COVID-19诊断和住院风险增加。
  • 对BMI≥40 kg/m2或BMI≤19 kg/m2的患者,需警惕COVID-19后续死亡风险。
  • 年轻肥胖患者可能面临更高的COVID-19不良结局风险,需加强预防建议。

局限性

  • 研究观察性设计,无法确定因果关系。
  • 需要更多研究揭示BMI与COVID-19结局关系的机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: A comprehensive understanding of the association between body mass index (BMI) and coronavirus disease 2019 (COVID-19) is still lacking. OBJECTIVE: To investigate associations between BMI and risk of COVID-19 diagnosis, hospitalization with COVID-19, and death after a COVID-19 diagnosis or hospitalization (subsequent death), accounting for potential effect modification by age and sex. DESIGN: Population-based cohort study. SETTING: Primary care records covering >80% of the Catalan population, linked to regionwide testing, hospital, and mortality records from March to May 2020. PARTICIPANTS: Adults (≥18 years) with at least 1 measurement of weight and height. MAIN OUTCOME MEASURES: Hazard ratios (HR) for each outcome. RESULTS: We included 2 524 926 participants. After 67 days of follow-up, 57 443 individuals were diagnosed with COVID-19, 10 862 were hospitalized with COVID-19, and 2467 had a subsequent death. BMI was positively associated with being diagnosed and hospitalized with COVID-19. Compared to a BMI of 22 kg/m2, the HR (95% CI) of a BMI of 31 kg/m2 was 1.22 (1.19-1.24) for diagnosis and 1.88 (1.75-2.03) and 2.01 (1.86-2.18) for hospitalization without and with a prior outpatient diagnosis, respectively. The association between BMI and subsequent death was J-shaped, with a modestly higher risk of death among individuals with BMIs ≤ 19 kg/m2 and a more pronounced increasing risk for BMIs ≥ 40 kg/m2. The increase in risk for COVID-19 outcomes was particularly pronounced among younger patients. CONCLUSIONS: There is a monotonic association between BMI and COVID-19 diagnosis and hospitalization risks but a J-shaped relationship with mortality. More research is needed to unravel the mechanisms underlying these relationships.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Recalde M, Pistillo A, Fernandez-Bertolin S, et al. Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans. J Clin Endocrinol Metab. 2021. PMID: 34297116. doi:10.1210/clinem/dgab546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。